CIBC Bank USA’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-4,334
Closed -$278K – 263
2015
Q2
$278K Sell
4,334
-200
-4% -$13.8K 0.05% 213
2015
Q1
$350K Sell
4,534
-6,250
-58% -$486K 0.06% 187
2014
Q4
$799K Sell
10,784
-50
-0.5% -$3.51K 0.14% 117
2014
Q3
$638K Sell
10,834
-56
-0.5% -$3.54K 0.13% 141
2014
Q2
$727K Hold
10,890
– – 0.14% 126
2014
Q1
$661K Sell
10,890
-820
-7% -$48.9K 0.14% 138
2013
Q4
$623K Sell
11,710
-3,690
-24% -$194K 0.14% 155
2013
Q3
$767K Sell
15,400
-31,930
-67% -$1.53M 0.19% 118
2013
Q2
$2.12M Buy
+47,330
New +$2.07M 0.12% 124

Other funds holding IDXX

CIBC Bank USA's IDXX Position: Q3 2015 in Review

CIBC Bank USA sold out of Idexx Laboratories (IDXX) in Q3 2015, closing a stake of 4,334 shares — an estimated $278K sold.

CIBC Bank USA first reported a position in IDXX in Q2 2013 and held it in 9 quarters. The position peaked at $2.12M in Q2 2013. 357 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

  • CIBC Bank USA reported no remaining Idexx Laboratories position as of Q3 2015 after selling out during the quarter.
  • CIBC Bank USA sold 4,334 Idexx Laboratories shares in Q3 2015, an estimated $278K.
  • CIBC Bank USA first reported a position in Idexx Laboratories in Q2 2013 and held it in 9 quarters.
  • CIBC Bank USA's Idexx Laboratories position peaked at $2.12M in Q2 2013.
  • 357 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on CIBC Bank USA's 13F filing for Q3 2015, filed 22 Oct 2015.